Obesity-induced hyperinsulinemia elevates insulin-like growth factor-1 (IGF-1) levels, which in turn promotes tumour growth and progression [4,5]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.